PIAZZA, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 5.666
EU - Europa 3.037
AS - Asia 1.320
SA - Sud America 34
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
Totale 10.088
Nazione #
US - Stati Uniti d'America 5.545
IT - Italia 781
SG - Singapore 488
CN - Cina 463
DE - Germania 422
SE - Svezia 418
IE - Irlanda 362
RU - Federazione Russa 276
UA - Ucraina 246
GB - Regno Unito 188
HK - Hong Kong 143
CA - Canada 115
AT - Austria 81
FI - Finlandia 78
VN - Vietnam 65
JP - Giappone 57
FR - Francia 51
TR - Turchia 36
NL - Olanda 34
DK - Danimarca 33
BE - Belgio 21
IN - India 19
AU - Australia 18
ES - Italia 17
CL - Cile 16
KR - Corea 16
ID - Indonesia 11
BR - Brasile 9
CH - Svizzera 8
TW - Taiwan 8
IR - Iran 6
MX - Messico 6
PT - Portogallo 6
AR - Argentina 5
EU - Europa 5
BY - Bielorussia 3
NO - Norvegia 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
GR - Grecia 2
KW - Kuwait 2
MD - Moldavia 2
PL - Polonia 2
PY - Paraguay 2
SC - Seychelles 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IL - Israele 1
MU - Mauritius 1
MY - Malesia 1
RO - Romania 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 10.088
Città #
Ann Arbor 1.452
Woodbridge 490
Singapore 427
Milan 367
Houston 357
Dublin 345
Chandler 309
Frankfurt am Main 299
Jacksonville 297
Wilmington 269
Fairfield 228
Ashburn 218
Dearborn 205
Santa Clara 192
New York 155
Princeton 143
Hong Kong 140
Nanjing 113
Seattle 112
Cambridge 87
Vienna 82
Lachine 55
Shanghai 49
Lawrence 38
Dong Ket 37
Boardman 35
Beijing 33
Altamura 31
Nanchang 30
Andover 23
Shenyang 23
Falls Church 21
Guangzhou 21
Brussels 20
London 20
Ottawa 20
San Diego 20
Jinan 19
Hebei 18
Helsinki 18
Rome 17
Changsha 16
Chicago 16
Norwalk 15
Tianjin 15
Toronto 15
Hangzhou 14
Los Angeles 14
Santiago 14
Ningbo 13
Fremont 12
Monmouth Junction 12
Mountain View 12
Buffalo 11
Jakarta 11
Lissone 11
Washington 11
Boston 10
Tokyo 10
Zhengzhou 10
Edmonton 9
Jiaxing 9
Rotterdam 9
Hefei 8
Leawood 8
Munich 8
Pune 8
Turin 8
University Park 8
Cantu 7
Grafing 7
Padova 7
Taizhou 7
Bologna 6
Bosco Marengo 6
Dallas 6
Huizen 6
Kilburn 6
Kunming 6
Prato 6
Auburn Hills 5
Brescia 5
Buenos Aires 5
Carate Brianza 5
Chengdu 5
Fuzhou 5
Haikou 5
Naples 5
Redmond 5
Saint Petersburg 5
Sydney 5
São Paulo 5
Barcelona 4
Bergamo 4
Cagliari 4
Copenhagen 4
Favaro Veneto 4
Istanbul 4
Lausanne 4
Lecce 4
Totale 7.314
Nome #
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? 552
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 397
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 387
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 372
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 334
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 282
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 276
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 239
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 229
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 218
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 193
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 185
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 184
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 176
Biological markers of vascular damage in Alzheimer’s disease patients 168
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 166
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 162
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 162
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 160
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 160
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 159
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 159
A challenging diagnosis of reversible “vascular” dementia: Cerebral amyloid angiopathy-related inflammation 156
Anti-Aβ autoantibodies in CAA-ri vs AD patients: different singers for the same ARIA? 155
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 155
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 144
CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network 138
Abrupt withdrawal of immunosuppressive drugs: a potential trigger for CAA-ri 136
Anti-abeta antibodies in CSF: markers for therapies? 135
Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease 130
Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 126
Metodo e kit per la rilevazione di anticorpi 126
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus. 125
Ubiquitin regulates GGA3-mediated degradation of BACE1 124
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 122
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 121
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 121
Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease 119
Increased levels of tissue factor pathway inhibitor in cerebrospinal fluid are related to neurodegeneration in alzheimer’s disease patients 118
Autologous anti-Aß antibodies in caa-ri: new biomarker for detection of Amyloid-Related Imaging Abnormalities (ARIA) during Aß-disease modifying therapies for AD 114
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 110
Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: Relevance for early neurological deterioration 109
Biomarkers in cerebral amyloid angiopathy-related inflammation 108
Inflammatory CAA and AD Biomarkers International Network 106
Effect of TNF-alpha on platelet glutamate uptake in Stroke patients 104
Symposium Immunotherapy Trials in CAA and AD: The ARIA paradox in AD and CAA: merely an adverse event or an out of tune proof of immunotherapy effectiveness? 103
A method and a kit for the detection of anti-beta amyloid antibodies 103
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 102
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 101
Non-vascular leucoencephalic dementia: The case of Cerebral Amyloid Angiopathy related inflammation 99
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 99
CSF anti-Aß autoantibodies as novel biomarker for Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer’s disease 94
Cerebral amyloid angiopathy-related inflammation. report of a case 92
Vascular damage and neurodegeneration 92
Pathogenetic Role of Anti- Aß Autoantibodies in CAA-related Inflammation: Implications for Amyloid-modifying Therapies in AD 91
Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation 90
Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice 88
Anti-Aß autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers Collaborative Network (iCAβ) 88
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 88
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 88
Author Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 87
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 77
Auto-antibodies to Aß in CSF 76
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 72
Données récentes sur l’Amyloïdose Cérébrale Inflammatoire. 71
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) 68
Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) 67
Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities 64
Large Collaborative Registries and Real-World Data to Manage Amyloid-Related Imaging Abnormalities 64
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model 56
Inflammatory CAA mechanisms and biomarkers– lessons for sporadic CAA diagnosis and treatment 54
CAA-ri and ARIA: Two Faces of the Same Coin? 51
Cerebral Amyloid Angiopathy-Related Inflammation 51
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 49
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study 48
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue 44
Abstract W MP89: Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 44
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case 43
The inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease Biomarkers International Network (iCAβ) initiative 32
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 19
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 9
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 8
Totale 10.794
Categoria #
all - tutte 34.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020959 0 0 0 0 116 168 229 75 133 87 121 30
2020/20211.237 53 70 132 149 71 80 120 82 126 135 78 141
2021/20221.039 96 86 114 97 74 106 33 31 42 76 74 210
2022/20231.727 204 419 146 146 147 232 96 91 172 16 37 21
2023/20241.309 44 67 59 62 180 274 229 82 133 32 34 113
2024/20251.318 163 417 317 134 287 0 0 0 0 0 0 0
Totale 10.794